103 related articles for article (PubMed ID: 8382163)
1. Expression of human minor histocompatibility antigen on cultured kidney cells.
Beck Y; Sekimata M; Nakayama S; Müller GA; Müller CA; Yamamoto J; Nagao T; Uchida H; Akiyama N; Kariyone A
Eur J Immunol; 1993 Feb; 23(2):467-72. PubMed ID: 8382163
[TBL] [Abstract][Full Text] [Related]
2. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
[TBL] [Abstract][Full Text] [Related]
3. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
[TBL] [Abstract][Full Text] [Related]
4. Allograft infiltrating cytotoxic T lymphocytes recognize kidney-specific human minor histocompatibility antigens.
Poindexter N; Shenoy S; Howard T; Flye MW; Mohanakumar T
Clin Transplant; 1997 Jun; 11(3):174-7. PubMed ID: 9193838
[TBL] [Abstract][Full Text] [Related]
5. Isolation of human minor histocompatibility peptides.
Sekimata M; Griem P; Egawa K; Rammensee HG; Takiguchi M
Int Immunol; 1992 Feb; 4(2):301-4. PubMed ID: 1622900
[TBL] [Abstract][Full Text] [Related]
6. Minor histocompatibility antigens, defined by graft-vs.-host disease-derived cytotoxic T lymphocytes, show variable expression on human skin cells.
De Bueger M; Bakker A; Van Rood JJ; Goulmy E
Eur J Immunol; 1991 Nov; 21(11):2839-44. PubMed ID: 1682155
[TBL] [Abstract][Full Text] [Related]
7. The role of the conserved residue in pocket A and the polymorphic residue in pocket E of HLA-B*3501 in presentation of human minor histocompatibility peptides to T cells.
Takiguchi M; Kawaguchi G; Sekimata M; Hiraiwa M; Kariyone A; Takamiya Y
Int Immunol; 1994 Sep; 6(9):1345-52. PubMed ID: 7819142
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
Burrows SR; Silins SL; Khanna R; Burrows JM; Rischmueller M; McCluskey J; Moss DJ
Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
[TBL] [Abstract][Full Text] [Related]
9. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens.
de Bueger M; Bakker A; Van Rood JJ; Van der Woude F; Goulmy E
J Immunol; 1992 Sep; 149(5):1788-94. PubMed ID: 1380540
[TBL] [Abstract][Full Text] [Related]
10. Possible involvement of allogeneic antigens recognised by donor-derived CD4 cytotoxic T cells in selective GVL effects after stem cell transplantation of patients with haematological malignancy.
Matsushita M; Yamazaki R; Ikeda H; Mori T; Sumimoto H; Fujita T; Okamoto S; Ikeda Y; Kawakami Y
Br J Haematol; 2006 Jan; 132(1):56-65. PubMed ID: 16371020
[TBL] [Abstract][Full Text] [Related]
11. Presentation of human minor histocompatibility antigens by HLA-B35 and HLA-B38 molecules.
Yamamoto J; Kariyone A; Akiyama N; Kano K; Takiguchi M
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2583-7. PubMed ID: 2157206
[TBL] [Abstract][Full Text] [Related]
12. Isolation of human minor histocompatibility peptides from cultured kidney cells.
Beck Y; Sekimata M; Nakayama S; Müller GA; Müller CA; Yamamoto J; Nagao T; Uchida H; Akiyama N; Kariyone A
Transplant Proc; 1993 Feb; 25(1 Pt 1):162-6. PubMed ID: 8382382
[No Abstract] [Full Text] [Related]
13. Polymorphism of human minor histocompatibility antigens: T cell recognition of human minor histocompatibility peptides presented by HLA-B35 subtype molecules.
Beck Y; Satz L; Takamiya Y; Nakayama S; Ling L; Ishikawa Y; Nagao T; Uchida H; Tokunaga K; Müller C
J Exp Med; 1995 Jun; 181(6):2037-48. PubMed ID: 7759996
[TBL] [Abstract][Full Text] [Related]
14. Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL.
Dolstra H; Fredrix H; Preijers F; Goulmy E; Figdor CG; de Witte TM; van de Wiel-van Kemenade E
J Immunol; 1997 Jan; 158(2):560-5. PubMed ID: 8992968
[TBL] [Abstract][Full Text] [Related]
15. Association of HER2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancer.
Yoshino I; Peoples GE; Goedegebuure PS; Maziarz R; Eberlein TJ
J Immunol; 1994 Mar; 152(5):2393-400. PubMed ID: 8133050
[TBL] [Abstract][Full Text] [Related]
16. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
Zorn E; Wang KS; Hochberg EP; Canning C; Alyea EP; Soiffer RJ; Ritz J
Clin Cancer Res; 2002 Jul; 8(7):2052-60. PubMed ID: 12114403
[TBL] [Abstract][Full Text] [Related]
17. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR
J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156
[TBL] [Abstract][Full Text] [Related]
18. A novel minor histocompatibility antigen recognized by HLA-A31 restricted cytotoxic T lymphocytes generated from HLA-identical bone marrow donor lymphocytes.
Yazaki M; Takahashi T; Andho M; Akatsuka Y; Ito T; Miyake Y; Ito Y; Nakamura S; Wada Y
Bone Marrow Transplant; 1999 Jul; 24(2):129-37. PubMed ID: 10455340
[TBL] [Abstract][Full Text] [Related]
19. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
Tomiyama H; Miwa K; Shiga H; Moore YI; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
J Immunol; 1997 May; 158(10):5026-34. PubMed ID: 9144523
[TBL] [Abstract][Full Text] [Related]
20. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.
Faber LM; van der Hoeven J; Goulmy E; Hooftman-den Otter AL; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
J Clin Invest; 1995 Aug; 96(2):877-83. PubMed ID: 7635982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
